Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|March 3, 2025
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian PerspectiveNatassia Tan, Christopher Zampogna, Kate Lynch, et al.
Hepatology Communications|April 27, 2023
Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary surveyNatasha Janko, Ammar Majeed, Warren Clements, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Hepatology (Baltimore, Md.)|October 6, 2015
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededThai P Hong, Paul Gow, Michael Fink, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 20, 2024
Efficacy of albumin use in decompensated cirrhosis and real-world adoption in AustraliaEric Kalo, Scott Read, Asma Baig, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varicesNik S Ding, Tin Nguyen, David M Iser, et al.
Scandinavian Journal of Gastroenterology|May 11, 2016
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world studyAdam Doyle, Philip Marsh, Raghubinder Gill, et al.
BMC Cancer|May 31, 2020
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationGauri Mishra, Anouk Dev, Eldho Paul, et al.
Gut|August 15, 2019
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?Mayur Garg, Simon G Royce, Chris Tikellis, et al.
Pageof 4